Preparation of Laboratory Report - Positive Test Specimens Clause Samples
The 'Preparation of Laboratory Report - Positive Test Specimens' clause outlines the requirements for documenting and reporting laboratory results when a specimen tests positive for a particular condition or substance. Typically, this clause specifies the information that must be included in the report, such as identification details, test methods used, and the results obtained, and may set timelines for when the report must be completed and delivered. Its core function is to ensure that positive test results are accurately and promptly communicated, thereby supporting effective decision-making and compliance with regulatory or contractual obligations.
Preparation of Laboratory Report - Positive Test Specimens. In the event that a specimen is found to be positive by the GC/MS process, the Laboratory shall prepare a written report. The original report shall be retained by the Laboratory. One copy, along with the sealed pre-test Declaration Form, shall be sent to the Medical Review Officer. The laboratory report shall contain the following information:
1. Employee confidential test identification number.
2. The drug identified.
3. The initial screening method.
4. The date screened.
5. The screening analyst's name.
6. The printed output from the immunoassay screening instrument pertaining to the batch of samples which includes the positive sample. That output will include the data from the relevant standards, blanks, quality control samples, and positive sample.
7. The confirmation method.
8. The date confirmed.
9. The confirming analyst's name and signature.
10. The graphs and reports pertaining to the gas chromatographmass spectrometer analysis of the relevant batch of samples and associated controls and quantitative standards.
11. The name and signature of the reviewing laboratory supervisor.
